Cansortium Inc. (CNTMF)
Cansortium Inc.
82 North East 26th Street
Suite 110
Miami, FL 33137
United States
(833) 735-8368
https://getfluent.com
Sector(es): Healthcare
Industria: Drug Manufacturers - Specialty & Generic
Empleados a tiempo completo:
Ejecutivos clave
| Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Mr. William M. Smith | Executive Chairman | 200k | N/D | N/D |
| Mr. Robert Beasley | CEO & Director | 560k | N/D | N/D |
| Ms. Samantha Senne Hymes | Executive Vice President of Operations | 213.85k | N/D | N/D |
| Mr. Victor Bindi | Director of Sales | 203.85k | N/D | N/D |
| Ms. Liora Boudin | Corporate Controller | 142.31k | N/D | N/D |
| Mr. Jeffrey Robert Batliner | Chief Financial Officer | N/D | N/D | 1965 |
| Dr. Jennifer McCafferty-Fernandez | Chief Science Officer | N/D | N/D | N/D |
| Mr. Jeffrey Reath | Consultant | 197.9k | N/D | N/D |
Descripción
Cansortium Inc., through its subsidiaries, produces and sells medical cannabis in Florida, Pennsylvania, and Texas. The company's medical cannabis products are offered in oral drops, capsules, topicals, syringes, dried flower, pre-rolls, cartridges, and edibles under the Fluent brand name. It also sells various third-party branded medical cannabis products. The company was incorporated in 2018 and is headquartered in Miami, Florida.
Gestión corporativa
La calificación ISS Governance QuickScore de Cansortium Inc. a partir del N/D es N/D. Las puntuaciones principales son Auditoría: N/D; Junta: N/D; Derechos del accionista: N/D; Compensación: N/D.
